Egypt to produce 40 million doses of Sputnik V jab
A new study identifies interleukin 11 as a marker of cancer-associated fibroblasts
22 April 2021Antidepressants: Evidence on safe discontinuation is lacking, concludes Cochrane review
22 April 2021Egypt to produce 40 million doses of Sputnik V jab
Egyptian firm Minapharm announced Thursday it will produce 40 million doses of the Russian vaccine Sputnik V to combat the COVID-19 pandemic.
